lacosamide ucb
ucb pharma s.a. - lacosamide - epilepsies, partial - antiepileptics, - lacosamide ucb is indicated as monotherapy and adjunctive therapy in the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 4 years of age with epilepsy.,
zyrtec 1mg/ml oral solution
ucb pharma sa 60 allee de la recherche, b-1070 brussels, belgium - cetirizine hydrochloride - oral solution - cetirizine hydrochloride 1 mg/ml - antihistamines for systemic use
nootropil (piracetam) 800 mg film-coated tablets
ucb pharma sa 60 allee de la recherche, b-1070 brussels, belgium - piracetam - film-coated tablet - piracetam 800 mg - psychoanaleptics
xyzal 0.5mg/ml oral solution
ucb pharma sa 60 allee de la recherche, b-1070 brussels, belgium - levocetirizine dihydrochloride - oral solution - levocetirizine dihydrochloride 0.5 mg/ml - antihistamines for systemic use
cirrus 5 mg/120 mg prolonged release tablets
ucb pharma sa 60 allee de la recherche, b-1070 brussels, belgium - cetirizine dihydrochloride, pseudoephedrine hydrochloride - prolonged-release tablet - cetirizine dihydrochloride 5 mg pseudoephedrine hydrochloride 120 mg - nasal preparations
zyrtec 10mg film-coated tablets
ucb pharma sa 60 allee de la recherche, b-1070 brussels, belgium - cetirizine hydrochloride - film-coated tablet - cetirizine hydrochloride 10 mg - antihistamines for systemic use
atarax
ucb pharma sa 60 allee de la recherche, b-1070 brussels, belgium - hydroxyzine hydrochloride - film-coated tablet - hydroxyzine hydrochloride 25 mg - psycholeptics
navidoxine
ucb pharma sa - meclozine hydrochloride 25 mg - tablet
atarax syrup
ucb pharma sa 60 allee de la recherche, b-1070 brussels, belgium - hydroxyzine hydrochloride - syrup - hydroxyzine hydrochloride 2 mg/ml - psycholeptics
vimpat
ucb pharma sa - lacosamide - epilepsy - antiepileptics, - vimpat is indicated as monotherapy and adjunctive therapy in the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 4 years of age with epilepsy.